Showing 2671-2680 of 20410 results for "".
Preventing Serious Infections in Immunocompromised Patients
https://reachmd.com/programs/living-rheum/preventing-serious-infections-in-immunocompromised-patients/32817/Preventing serious infections should be a priority when treating patients with immune-mediated inflammatory diseases, especially those receiving immunosuppressive therapies. By assessing patients’ level of immunocompetence, clinicians can better tailor vaccination strategies and optimize infection pInnovations in IgAN Care: Addressing Challenges with Therapeutic Advances
https://reachmd.com/programs/clinicians-roundtable/innovations-in-igan-care-addressing-challenges-with-therapeutic-advances/37217/The available treatment options and even the current guidelines for the management of IgA nephropathy (IgAN) come with several limitations. Fortunately, new therapies are on the horizon that can help us address those challenges and slow disease progression in IgAN. Here with Dr. Charles Turck to disEvolving Strategies in Resectable NSCLC: Insights from ASCO and ASTRO 2025
https://reachmd.com/programs/deep-breaths-updates-chest/evolving-strategies-in-resectable-nsclc-insights-from-asco-and-astro-2025/35982/Recent data from ASCO and ASTRO 2025 are redefining standards of care for resectable non-small cell lung cancer (NSCLC). Drs. Gerard Silvestri, Mariam Alexander, Anurag Singh, and Jessica Donington review these updates on the importance of molecular testing, careful surgical selection, and multidiscStrengthening Patient Trust in ILD Care: Strategies from the First 5 Minutes Framework
https://reachmd.com/programs/deep-breaths-updates-chest/strengthening-patient-trust-in-ild-care-strategies-from-the-first-5-minutes-framework/36129/Effectively supporting patients with interstitial lung disease (ILD) requires more than just clinical knowledge—it demands strong, trust-based communication from the very first moments spent with a patient. Dr. Susan Corbridge sits down with Drs. Brad Bemiss and Debasree Banerjee to explore how thePreventive Care Essentials for Patients with IBD: Reviewing ACG Guideline Updates
https://reachmd.com/programs/gi-insights/program-name/36500/A 2025 update to the American College of Gastroenterology (ACG)'s guideline on preventive care in inflammatory bowel disease (IBD) includes key changes impacting vaccine recommendations, dermatologic screening, and care coordination. Dr. Peter Buch sits down with Dr. Francis Farraye, lead author ofManaging Postoperative Infections: When and How to Use Antibiotics
https://reachmd.com/programs/clinicians-roundtable/managing-postoperative-infections-when-and-how-to-use-antibiotics/36426/For post-surgical patients, especially those with comorbidities or immune compromise, infection risk remains high. As a result, knowing how and when to initiate antibiotics is critical. Tune in to hear Dr. Paul Kim discuss the clinical signs that prompt him to use antibiotics and his process for selChallenging Migraine Stereotypes: Improving Patient Care Through Empathy and Insight
https://reachmd.com/programs/frontlines-migraine/challenging-migraine-stereotypes-improving-patient-care-through-empathy-and-insight/36154/Stigma and misconceptions around migraine can lead to misdiagnosis, undertreatment, and inequitable care, especially in emergency and primary care settings. Listening to patients, validating lived experiences, and enhancing clinical training to recognize migraine as a complex neurologic disorImproving Health Literacy to Empower Adolescents With Sickle Cell Disease
https://reachmd.com/programs/project-oncology/improving-health-literacy-to-empower-adolescents-with-sickle-cell-disease/35927/Health literacy directly influences outcomes for patients with sickle cell disease, especially during the critical transition from pediatric to adult care. Validated tools to help assess comprehension and simplified, patient-informed education materials are essential for optimal care. HearIdentifying CIDP: A Guide to Risk Profiles and Clinical Presentation
https://reachmd.com/programs/frontlines-cidp/identifying-cidp-a-guide-to-risk-profiles-and-clinical-presentation/33073/Early recognition of CIDP is essential to prevent irreversible damage and guide appropriate treatment, but its varied presentations can complicate diagnosis. Ryan Quigley sits down with Dr. Nicolas Dubuisson to discuss the clinical hallmarks of CIDP, its variants, and key risk factors. Dr. DubuissonInvestigating the Impact of Exercise on Cancer Immunotherapy Outcomes
https://reachmd.com/programs/project-oncology/investigating-the-impact-of-exercise-on-cancer-immunotherapy-outcomes/35680/Although immunotherapy has helped reshape cancer care, patient responses to this treatment approach vary widely. But according to a recent systematic review, exercise could play a role in enhancing immune function and outcomes during immunotherapy treatment. Learn more about the findings with Dr. Sa